News

FDA’s “Creativity and Innovation Award” given to Coleman’s Jake Jackson

Posted in:News & Events

We are delighted to announce that Coleman’s Quality Assurance Specialist, Jake Jackson, was selected by the Food and Drug Administration’s Office of Operations to receive the Federal Drug Administration’s (FDA) “Creativity and Innovation Award” as part of the 2022 Honor Awards.

Coleman's Jake Jackson Wins the Food and Drug Administration's Creativity and Innovation Award
Coleman’s Jake Jackson Wins the Food and Drug Administration’s Creativity and Innovation Award

Jake received the award for work with the FDA’s Sustainability Program for determination and creativity, which led to the ongoing success of the Sustainability Program through innovative virtual approaches to information sharing. This exemplary and innovative work distinguishes The Coleman Group and enables us to continue providing platinum-level service to our clients.

 

Congratulations, Jake!

Coleman Group Supports Vaccine Hesitancy Research

Posted in:Archives

Reaching the Vaccine-Averse: The Role of Cue-based Trust in COVID-19 Vaccination Social Media Vlogs Addressing Vaccine Hesitancy

The Coleman Group Inc. is proud to support public health data mapping and behavior change research. Our recent vaccine hesitancy work with Dr. Alexander Pfeuffer and our company’s original research on COVID-19 behavior change among resistant populations has led to Coleman’s contribution to further work in the field.

Read more >>

Portrait of family after getting covid-19 vaccine. Recognizing the potential in depicting regular individuals’ vaccination experiences in increasing COVID-19 vaccine uptake on social media platforms, organizations such as universities, companies, or government agencies have begun sharing regular individuals’ experiences throughout the vaccination process to encourage others to also obtain the vaccine.

Read more >>